Brain imaging in the study of Alzheimer's disease
Open accessThe DOI matches its Crossref record; 80 of the 80 references it cites were found in a registry or an index.
Abstract
Over the last 20 years, there has been extraordinary progress in brain imaging research and its application to the study of Alzheimer's disease (AD). Brain imaging researchers have contributed to the scientific understanding, early detection and tracking of AD. They have set the stage for imaging techniques to play growing roles in the clinical setting, the evaluation of disease-modifying treatments, and the identification of demonstrably effective prevention therapies. They have developed ground-breaking methods, including positron emission tomography (PET) ligands to measure fibrillar amyloid-β (Aβ) deposition, new magnetic resonance imaging (MRI) pulse sequences, and powerful image analysis techniques, to help in these endeavors. Additional work is needed to develop even more powerful imaging methods, to further clarify the relationship and time course of Aβ and other disease processes in the predisposition to AD, to establish the role of brain imaging methods in the clinical setting, and to provide the scientific means and regulatory approval pathway needed to evaluate the range of promising disease-modifying and prevention therapies as quickly as possible. Twenty years from now, AD may not yet be a distant memory, but the best is yet to come.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123
Albert, M. S., DeKosky, S. T., Dickson, D., Dubois, B., Feldman, H. H., Fox, N. C., Gamst, A., Holtzman, D. M., Jagust, W. J., Petersen, R. C., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.008 · Cited by 10,152
Self-citationSperling, R. A., Aisen, P. S., Beckett, L. A., Bennett, D. A., Craft, S., Fagan, A. M., Iwatsubo, T., Jack, C. R., Kaye, J., Montine, T. J., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.003 · Cited by 7,155 · cited 3×
“…Selkoe, 2002)) in the living human brain (Klunk et al., 2004), the role that imaging studies have already played in the reconceptualization of AD (Sperling et al., 2011), the extraordinary opportunities researchers have to help in the scientific fight against this devastating disease, and the…”
BackgroundSelf-citationHypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade
Jack, C. R., Knopman, D. S., Jagust, W. J., Shaw, L. M., Aisen, P. S., Weiner, M. W., Petersen, R. C., & Trojanowski, J. Q. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70299-6 · Cited by 4,806 · cited 3×
“The combined use of multiple imaging modalities has also resulted in new formulations of the sequence of pathological events in AD as proposed in a recent review (Jack et al., 2010).”
BackgroundSelf-citationGreicius, M. D., Srivastava, G., Reiss, A. L., & Menon, V. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308627101 · Cited by 3,684 · cited 4×
“As noted, the DMN is disrupted in AD (Greicius et al., 2004) and in resting state connectivity studies in normal older people with asymptomatic fibrillar Aβ deposition (Hedden et al., 2009; Sheline et al., 2010); there is also some evidence that subcomponents of this network show increased…”
BackgroundInfluentialBuckner, R. L., Sepulcre, J., Talukdar, T., Krienen, F. M., Liu, H., Hedden, T., Andrews-Hanna, J. R., Sperling, R. A., & Johnson, K. A. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.5062-08.2009 · Cited by 2,862
Neurodegenerative Diseases Target Large-Scale Human Brain Networks
Seeley, W. W., Crawford, R. K., Zhou, J., Miller, B. L., & Greicius, M. D. (2009) · Neuron · doi:10.1016/j.neuron.2009.03.024 · Cited by 2,350 · cited 1×
“…patterns of neural connectivity in a number of different networks, suggesting that intrinsic functional and structural connectivity somehow mediates the regional progression of disorders as disparate as AD, frontotemporal lobar degeneration, and progressive supranuclear palsy (Seeley et al., 2009).”
BackgroundBuckner, R. L., Snyder, A. Z., Shannon, B. J., LaRossa, G., Sachs, R., Fotenos, A. F., Sheline, Y. I., Klunk, W. E., Mathis, C. A., Morris, J. C., et al. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.2177-05.2005 · Cited by 2,140 · cited 2×
“Subsequent work has shown that this network anatomically overlaps with both Aβ deposition and the pattern of MRI regional atrophy and PET-FDG hypometabolism (Buckner et al., 2005) (Fig.”
BackgroundObservations on the brains of demented old people
Tomlinson, B. E., Blessed, G., & Roth, M. (1970) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(70)90063-8 · Cited by 2,084
Petersen, R. C., Stevens, J. C., Ganguli, M., Tangalos, E. G., Cummings, J. L., & DeKosky, S. T. (2001) · Neurology · doi:10.1212/wnl.56.9.1133 · Cited by 2,065 · cited 1×
“Existing American Academy of Neurology practice parameters for the diagnosis of AD recommend CT or MR imaging only to rule out treatable structural pathology (Knopman et al., 2001) while MCI practice parameters do not address imaging at all (Petersen et al., 2001).”
Revising the definition of Alzheimer's disease: a new lexicon
Dubois, B., Feldman, H. H., Jacova, C., Cummings, J. L., DeKosky, S. T., Barberger-Gateau, P., Delacourte, A., Frisoni, G., Fox, N. C., Galasko, D., et al. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70223-4 · Cited by 1,869 · cited 1×
“…propose the use of medial temporal atrophy, temporoparietal hypometabolism, and amyloid imaging (as well as CSF Aβ and tau measurements) as supportive features for a diagnosis of AD in the context of the core diagnostic feature of slowly progressive episodic memory loss (Dubois et al., 2007, 2010).”
BackgroundMetabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease
Minoshima, S., Giordani, B., Berent, S., Frey, K. A., Foster, N. L., & Kuhl, D. E. (1997) · Annals of Neurology · doi:10.1002/ana.410420114 · Cited by 1,802 · cited 1×
“…as the illness becomes more severe (Alexander et al., 2002a; Chen et al., 2010; Choo et al., 2007; Drzezga et al., 2005b; Foster et al., 1983; Herholz et al., 2002; Hoffman et al., 2000; Langbaum et al., 2009; Li et al., 2008; Minoshima et al., 1997; Mosconi et al., 2009; Reiman et al., 1996).”
Palop, J. J., Chin, J., Roberson, E. D., Wang, J., Thwin, M. T., Bien-Ly, N., Yoo, J., Ho, K. O., Yu, G.-Q., Kreitzer, A., et al. (2007) · Neuron · doi:10.1016/j.neuron.2007.07.025 · Cited by 1,653 · cited 2×
“Alternative explanations include dedifferentiation of cortical function, and aberrant excitation, a finding that has also been seen in vivo in animal models of AD (Palop et al., 2007).”
BackgroundLong-term Effects of Cognitive Training on Everyday Functional Outcomes in Older Adults
Willis, S. L., Tennstedt, S. L., Marsiske, M., Ball, K., Elias, J., Koepke, K. M., Morris, J. N., Rebok, G. W., Unverzagt, F. W., Stoddard, A. M., et al. (2006) · JAMA · doi:10.1001/jama.296.23.2805 · Cited by 1,496 · cited 2×
“When one considers the growing number of clinically affected AD patients, the healthy lifestyle interventions suggested but not proven to reduce the risk of AD symptoms (Haag et al., 2009; Lautenschlager et al., 2008; Peila et al., 2006; Scarmeas et al., 2009; Szekely et al., 2008; Wang et al., 2002; Willis et al., 20…”
BackgroundKnopman, D. S., DeKosky, S. T., Cummings, J. L., Chui, H., Corey–Bloom, J., Relkin, N., Small, G. W., Miller, B., & Stevens, J. C. (2001) · Neurology · doi:10.1212/wnl.56.9.1143 · Cited by 1,410
Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment
Jack, C. R., Petersen, R. C., Xu, Y. C., O’Brien, P. C., Smith, G. E., Ivnik, R. J., Boeve, B. F., Waring, S. C., Tangalos, E. G., & Kokmen, E. (1999) · Neurology · doi:10.1212/wnl.52.7.1397 · Cited by 1,404 · cited 1×
“There is of course also evidence that FDG-PET and MRI are predictive of decline (Chetelat et al., 2003a; Jack et al., 1999).”
BackgroundReiman, E. M., Caselli, R. J., Yun, L. S., Chen, K., Bandy, D., Minoshima, S., Thibodeau, S. N., & Osborne, D. (1996) · New England Journal of Medicine · doi:10.1056/nejm199603213341202 · Cited by 1,366 · cited 2×
“…as the illness becomes more severe (Alexander et al., 2002a; Chen et al., 2010; Choo et al., 2007; Drzezga et al., 2005b; Foster et al., 1983; Herholz et al., 2002; Hoffman et al., 2000; Langbaum et al., 2009; Li et al., 2008; Minoshima et al., 1997; Mosconi et al., 2009; Reiman et al., 1996).”
BackgroundSelf-citationNeuropathology of older persons without cognitive impairment from two community-based studies
Bennett, D. A., Schneider, J. A., Arvanitakis, Z., Kelly, J. F., Aggarwal, N. T., Shah, R. C., & Wilson, R. S. (2006) · Neurology · doi:10.1212/01.wnl.0000219668.47116.e6 · Cited by 1,336 · cited 1×
“For example, it has long been known that older individuals can show pronounced deposition of Aβ in the form of neuritic plaques without having evidence of cognitive impairment (Bennett et al., 2006; Tomlinson et al., 1968).”
BackgroundPatterns of Brain Activation in People at Risk for Alzheimer's Disease
Bookheimer, S. Y., Strojwas, M. H., Cohen, M. S., Saunders, A. M., Pericak-Vance, M. A., Mazziotta, J. C., & Small, G. W. (2000) · New England Journal of Medicine · doi:10.1056/nejm200008173430701 · Cited by 1,328
Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Aβ 42 in humans
Fagan, A. M., Mintun, M. A., Mach, R. H., Lee, S., Dence, C. S., Shah, A. R., LaRossa, G. N., Spinner, M. L., Klunk, W. E., Mathis, C. A., et al. (2006) · Annals of Neurology · doi:10.1002/ana.20730 · Cited by 1,246 · cited 2×
“It has been suggested that fibrillar Aβ deposition is associated with non-progressive reductions in CSF Aβ42 levels and that it anticipates downstream brain imaging and CSF changes (Fagan et al., 2006), including progressive MRI measurements of brain shrinkage, progressive PET measurements or rCMRgl decline, non-progr…”
BackgroundDickerson, B. C., Bakkour, A., Salat, D. H., Feczko, E., Pacheco, J., Greve, D. N., Grodstein, F., Wright, C. I., Blacker, D., Rosas, H. D., et al. (2009) · Cerebral Cortex · doi:10.1093/cercor/bhn113 · Cited by 1,153
Use of Florbetapir-PET for Imaging β-Amyloid Pathology
Clark, C. M. (2011) · JAMA · doi:10.1001/jama.2010.2008 · Cited by 1,117
Imaging β-amyloid burden in aging and dementia
Rowe, C. C., Ng, S., Ackermann, U., Gong, S. J., Pike, K., Savage, G., Cowie, T. F., Dickinson, K. L., Maruff, P., Darby, D., et al. (2007) · Neurology · doi:10.1212/01.wnl.0000261919.22630.ea · Cited by 1,104 · cited 1×
“…saturated by the time patients have MCI (Doraiswamy et al., 2009; Forsberg et al., 2008; Grimmer et al., 2009; Jack et al., 2008; Kemppainen et al., 2007; Klunk et al., 2004, 2006; Morris et al., 2009; Resnick et al., 2010; Rowe et al., 2007, 2010; Villemagne et al., 2011; Wolk et al., 2009) (Fig.”
BackgroundJack, C. R., Lowe, V. J., Weigand, S. D., Wiste, H. J., Senjem, M. L., Knopman, D. S., Shiung, M. M., Gunter, J. L., Boeve, B. F., Kemp, B. J., et al. (2009) · Brain · doi:10.1093/brain/awp062 · Cited by 1,099
In-vivo measurement of activated microglia in dementia
Cagnin, A., Brooks, D. J., Kennedy, A. M., Gunn, R. N., Myers, R., Turkheimer, F. E., Jones, T., & Banati, R. B. (2001) · The Lancet · doi:10.1016/s0140-6736(01)05625-2 · Cited by 1,054
[ 11 C]PIB in a nondemented population: Potential antecedent marker of Alzheimer disease
Mintun, M. A., LaRossa, G. N., Sheline, Y. I., Dence, C. S., Lee, S. Y., Mach, R. H., Klunk, W. E., Mathis, C. A., DeKosky, S. T., & Morris, J. C. (2006) · Neurology · doi:10.1212/01.wnl.0000228230.26044.a4 · Cited by 1,036
Sperling, R. A., LaViolette, P. S., O'Keefe, K., O'Brien, J., Rentz, D. M., Pihlajamaki, M., Marshall, G., Hyman, B. T., Selkoe, D. J., Hedden, T., et al. (2009) · Neuron · doi:10.1016/j.neuron.2009.07.003 · Cited by 1,027 · cited 2×
“Failure to deactivate the same regions has been reported in aging and in early stage AD (Lustig et al., 2003), and most recently has been associated with fibrillar Aβ deposition in asymptomatic normal older people performing a memory encoding task (Sperling et al., 2009).”
BackgroundAmyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging
Rowe, C. C., Ellis, K. A., Rimajova, M., Bourgeat, P., Pike, K. E., Jones, G., Fripp, J., Tochon-Danguy, H., Morandeau, L., O'Keefe, G., et al. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.04.007 · Cited by 986 · cited 2×
“…saturated by the time patients have MCI (Doraiswamy et al., 2009; Forsberg et al., 2008; Grimmer et al., 2009; Jack et al., 2008; Kemppainen et al., 2007; Klunk et al., 2004, 2006; Morris et al., 2009; Resnick et al., 2010; Rowe et al., 2007, 2010; Villemagne et al., 2011; Wolk et al., 2009) (Fig.”
BackgroundFunctional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia
Reiman, E. M., Chen, K., Alexander, G. E., Caselli, R. J., Bandy, D., Osborne, D., Saunders, A. M., & Hardy, J. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2635903100 · Cited by 977 · cited 4×
“Why have some researchers been able to show brain changes in young adults at genetic risk for AD before any evidence of fibrillar or soluble Aβ accumulation (Reiman et al., 2004)? The information may give researchers an important resource about the earliest synaptic or peri-synaptic changes associated with the predisp…”
BackgroundInfluentialSelf-citationJack, C. R., Lowe, V. J., Senjem, M. L., Weigand, S. D., Kemp, B. J., Shiung, M. M., Knopman, D. S., Boeve, B. F., Klunk, W. E., Mathis, C. A., et al. (2008) · Brain · doi:10.1093/brain/awm336 · Cited by 958 · cited 1×
“…that fibrillar Aβ levels are virtually saturated by the time patients have MCI (Doraiswamy et al., 2009; Forsberg et al., 2008; Grimmer et al., 2009; Jack et al., 2008; Kemppainen et al., 2007; Klunk et al., 2004, 2006; Morris et al., 2009; Resnick et al., 2010; Rowe et al., 2007, 2010;…”
BackgroundPost-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease
Ikonomovic, M. D., Klunk, W. E., Abrahamson, E. E., Mathis, C. A., Price, J. C., Tsopelas, N. D., Lopresti, B. J., Ziolko, S., Bi, W., Paljug, W. R., et al. (2008) · Brain · doi:10.1093/brain/awn016 · Cited by 933 · cited 1×
“…between PET measurements of fibrillar Aβ at the end of life and subsequent neuropathological measurements of fibrillar Aβ (Clark et al., 2011; Ikonomovic et al., 2008; Sojkova et al., 2011), and the first of these ligands (florbetapir F18) is now being considered for regulatory agency…”
BackgroundPhysical Activity, Diet, and Risk of Alzheimer Disease
Scarmeas, N. (2009) · JAMA · doi:10.1001/jama.2009.1144 · Cited by 916
Longitudinal assessment of Aβ and cognition in aging and Alzheimer disease
Villemagne, V. L., Pike, K. E., Chételat, G., Ellis, K. A., Mulligan, R. S., Bourgeat, P., Ackermann, U., Jones, G., Szoeke, C., Salvado, O., et al. (2011) · Annals of Neurology · doi:10.1002/ana.22248 · Cited by 833
Discrimination between Alzheimer dementia and controls by automated analysis of multicenter FDG PET
Herholz, K., Salmon, E., Perani, D., Baron, J.-C., Holthoff, V., Frölich, L., Schönknecht, P., Ito, K., Mielke, R., & Kalbe, E. (2002) · NeuroImage · doi:10.1006/nimg.2002.1208 · Cited by 832 · cited 1×
“…brain as the illness becomes more severe (Alexander et al., 2002a; Chen et al., 2010; Choo et al., 2007; Drzezga et al., 2005b; Foster et al., 1983; Herholz et al., 2002; Hoffman et al., 2000; Langbaum et al., 2009; Li et al., 2008; Minoshima et al., 1997; Mosconi et al., 2009; Reiman et al.,…”
BackgroundAPOE predicts amyloid‐beta but not tau Alzheimer pathology in cognitively normal aging
Morris, J. C., Roe, C. M., Xiong, C., Fagan, A. M., Goate, A. M., Holtzman, D. M., & Mintun, M. A. (2010) · Annals of Neurology · doi:10.1002/ana.21843 · Cited by 830
Comparison of different MRI brain atrophy rate measures with clinical disease progression in AD
Jack, C. R., Shiung, M. M., Gunter, J. L., O’Brien, P. C., Weigand, S. D., Knopman, D. S., Boeve, B. F., Ivnik, R. J., Smith, G. E., Cha, R. H., et al. (2004) · Neurology · doi:10.1212/01.wnl.0000110315.26026.ef · Cited by 827 · cited 1×
“…and entorhinal cortex size appear to correspond to early memory decline and anticipate progression to more severe clinical stages, including mild cognitive impairment (MCI) and Alzheimer's dementia (de Leon et al., 1989; Dickerson et al., 2001; Jack et al., 2004, 2005; Kaye et al., 1997).”
BackgroundCerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer’s disease
Small, G. W., Ercoli, L. M., Silverman, D. H. S., Huang, S.-C., Komo, S., Bookheimer, S. Y., Lavretsky, H., Miller, K., Siddarth, P., Rasgon, N. L., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.090106797 · Cited by 790 · cited 1×
“…Press. early-onset AD, and those with higher rates of subsequent cognitive decline) (Kennedy et al., 1995; Langbaum et al., 2010; Mosconi et al., 2006, 2008; Reiman et al., 1996, 2001, 2004, 2005; Rimajova et al., 2008; Scholl et al., 2011; Small et al., 1995, 2000; Villemagne et al., 2009) (Fig.”
BackgroundPike, K. E., Savage, G., Villemagne, V. L., Ng, S., Moss, S. A., Maruff, P., Mathis, C. A., Klunk, W. E., Masters, C. L., & Rowe, C. C. (2007) · Brain · doi:10.1093/brain/awm238 · Cited by 789 · cited 1×
“…and that the magnitude and spatial extent of fibrillar Aβ are associated with older age and the genetic risk for late-onset AD (Aizenstein et al., 2008; Mintun et al., 2006; Morris et al., 2010; Pike et al., 2007; Reiman et al., 2009; Rowe et al., 2010; Small et al., 2009; Villemagne et al., 2011).”
BackgroundReiman, E. M., Chen, K., Liu, X., Bandy, D., Yu, M., Lee, W., Ayutyanont, N., Keppler, J., Reeder, S. A., Langbaum, J. B. S., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0900345106 · Cited by 785 · cited 2×
“PET amyloid imaging has confirmed the finding of substantial Aβ in normal older people, particularly as related to apolipoprotein E genotype (Morris et al., 2010; Reiman et al., 2009), and it has permitted the simultaneous examination of cognition in great detail.”
BackgroundSelf-citationRegional aerobic glycolysis in the human brain
Vaishnavi, S. N., Vlassenko, A. G., Rundle, M. M., Snyder, A. Z., Mintun, M. A., & Raichle, M. E. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1010459107 · Cited by 738
Functional deactivations: Change with age and dementia of the Alzheimer type
Lustig, C., Snyder, A. Z., Bhakta, M., O'Brien, K. C., McAvoy, M., Raichle, M. E., Morris, J. C., & Buckner, R. L. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2235925100 · Cited by 720
Rinne, J. O., Brooks, D. J., Rossor, M. N., Fox, N. C., Bullock, R., Klunk, W. E., Mathis, C. A., Blennow, K., Barakos, J., Okello, A. A., et al. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70043-0 · Cited by 701
Observations on the brains of non-demented old people
Tomlinson, B. E., Blessed, G., & Roth, M. (1968) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(68)90154-8 · Cited by 681
Comparing predictors of conversion and decline in mild cognitive impairment
Landau, S. M., Harvey, D., Madison, C. M., Reiman, E. M., Foster, N. L., Aisen, P. S., Petersen, R. C., Shaw, L. M., Trojanowski, J. Q., Jack, C. R., et al. (2010) · Neurology · doi:10.1212/wnl.0b013e3181e8e8b8 · Cited by 616
Self-citationFDG-PET improves accuracy in distinguishing frontotemporal dementia and Alzheimer's disease
Foster, N. L., Heidebrink, J. L., Clark, C. M., Jagust, W. J., Arnold, S. E., Barbas, N. R., DeCarli, C. S., Scott Turner, R., Koeppe, R. A., Higdon, R., et al. (2007) · Brain · doi:10.1093/brain/awm177 · Cited by 608 · cited 2×
“degeneration (Foster et al., 2007) and how imaging findings may be related to pathology (Gosche et al.”
BackgroundSelf-citationSmall, G. W. (1995) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1995.03520360056039 · Cited by 604
Disruption of Functional Connectivity in Clinically Normal Older Adults Harboring Amyloid Burden
Hedden, T., Van Dijk, K. R. A., Becker, J. A., Mehta, A., Sperling, R. A., Johnson, K. A., & Buckner, R. L. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.3189-09.2009 · Cited by 598
Sheline, Y. I., Raichle, M. E., Snyder, A. Z., Morris, J. C., Head, D., Wang, S., & Mintun, M. A. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.08.024 · Cited by 597
Bateman, R. J., Aisen, P. S., De Strooper, B., Fox, N. C., Lemere, C. A., Ringman, J. M., Salloway, S., Sperling, R. A., Windisch, M., & Xiong, C. (2010) · Alzheimer's Research & Therapy · doi:10.1186/alzrt59 · Cited by 573 · cited 3×
“…therapies in clinically affected patients, and evaluate the ability of even more investigational Aβ-modifying treatments to slow down the accumulation of fibrillar Aβ in presymptomatic AD (i.e., prevention) trials (Bateman et al., 2011; Reiman and Langbaum, 2009; Reiman et al., 2010, 2011).”
BackgroundHippocampal formation glucose metabolism and volume losses in MCI and AD
De Santi, S., de Leon, M. J., Rusinek, H., Convit, A., Tarshish, C. Y., Roche, A., Tsui, W. H., Kandil, E., Boppana, M., Daisley, K., et al. (2001) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00230-5 · Cited by 548 · cited 1×
“In a smaller number of studies, CMRgl reductions have also been reported in hippocampal and entorhinal cortex regions-of-interest (De Santi et al., 2001; Mosconi et al., 2004b, 2005).”
BackgroundAlexander, G. E., Chen, K., Pietrini, P., Rapoport, S. I., & Reiman, E. M. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.5.738 · Cited by 532
Self-citationChételat, G., Landeau, B., Eustache, F., Mézenge, F., Viader, F., de la Sayette, V., Desgranges, B., & Baron, J.-C. (2005) · NeuroImage · doi:10.1016/j.neuroimage.2005.05.015 · Cited by 526 · cited 1×
“…those MCI patients most likely to show subsequent clinical progression over the next 12–18 months, providing an enrichment strategy by which to reduce sample size and treatment duration in MCI trials (Chételat et al., 2005a, 2005b; Drzezga et al., 2005a; Jack et al., 2005; Mosconi et al., 2004a).”
BackgroundEdison, P., Archer, H. A., Gerhard, A., Hinz, R., Pavese, N., Turkheimer, F. E., Hammers, A., Tai, Y. F., Fox, N., Kennedy, A., et al. (2008) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.08.001 · Cited by 513 · cited 2×
“…receptor that is expressed on activated microglia, have shown conflicting results, with evidence of both increases (Cagnin et al., 2001; Edison et al., 2008; Okello et al., 2009a) and lack of change in AD and MCI (Wiley et al., 2009); other PET tracers for inflammation that are under…”
BackgroundBrain atrophy rates predict subsequent clinical conversion in normal elderly and amnestic MCI
Jack, C. R., Shiung, M. M., Weigand, S. D., O’Brien, P. C., Gunter, J. L., Boeve, B. F., Knopman, D. S., Smith, G. E., Ivnik, R. J., Tangalos, E. G., et al. (2005) · Neurology · doi:10.1212/01.wnl.0000180958.22678.91 · Cited by 492
White matter changes in mild cognitive impairment and AD: a diffusion tensor imaging study
Medina, D., deToledo-Morrell, L., Urresta, F., Gabrieli, J. D. E., Moseley, M., Fleischman, D., Bennett, D. A., Leurgans, S., Turner, D. A., & Stebbins, G. T. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.03.026 · Cited by 492 · cited 2×
“loss of white matter integrity in AD and MCI patients (Medina et al., 2006).”
BackgroundMosconi, L., Mistur, R., Switalski, R., Tsui, W. H., Glodzik, L., Li, Y., Pirraglia, E., De Santi, S., Reisberg, B., Wisniewski, T., et al. (2009) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-008-1039-z · Cited by 487
Aβ amyloid and glucose metabolism in three variants of primary progressive aphasia
Rabinovici, G. D., Jagust, W. J., Furst, A. J., Ogar, J. M., Racine, C. A., Mormino, E. C., O'Neil, J. P., Lal, R. A., Dronkers, N. F., Miller, B. L., et al. (2008) · Annals of Neurology · doi:10.1002/ana.21451 · Cited by 477
Self-citationMorris, J. C., Roe, C. M., Grant, E. A., Head, D., Storandt, M., Goate, A. M., Fagan, A. M., Holtzman, D. M., & Mintun, M. A. (2009) · Archives of Neurology · doi:10.1001/archneurol.2009.269 · Cited by 476
Preclinical prediction of Alzheimer's disease using SPECT
Johnson, K. A., Jones, K., Holman, B. L., Becker, J. A., Spiers, P. A., Satlin, A., & Albert, M. S. (1998) · Neurology · doi:10.1212/wnl.50.6.1563 · Cited by 471 · cited 2×
“shown to predict decline in MCI (Johnson et al., 1998) and are related to autopsy findings (Bonte et al.”
ResultReiman, E. M., Caselli, R. J., Chen, K., Alexander, G. E., Bandy, D., & Frost, J. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.061509598 · Cited by 467 · cited 1×
“…Press. early-onset AD, and those with higher rates of subsequent cognitive decline) (Kennedy et al., 1995; Langbaum et al., 2010; Mosconi et al., 2006, 2008; Reiman et al., 1996, 2001, 2004, 2005; Rimajova et al., 2008; Scholl et al., 2011; Small et al., 1995, 2000; Villemagne et al., 2009) (Fig.”
BackgroundSelf-citationExtent and distribution of white matter hyperintensities in normal aging, MCI, and AD
Yoshita, M., Fletcher, E., Harvey, D., Ortega, M., Martinez, O., Mungas, D. M., Reed, B. R., & DeCarli, C. S. (2006) · Neurology · doi:10.1212/01.wnl.0000249119.95747.1f · Cited by 434 · cited 1×
“…permits researchers to detect the cerebral white matter hyperintensities suggestive of vascular disease, which is commonly found in AD patients (Yoshita et al., 2006) and may contribute to their cognitive decline (Brickman et al., 2008), and which could be used to help characterize a…”
BackgroundA meta-analysis of diffusion tensor imaging in mild cognitive impairment and Alzheimer's disease
Sexton, C. E., Kalu, U. G., Filippini, N., Mackay, C. E., & Ebmeier, K. P. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.05.019 · Cited by 410 · cited 2×
“Both AD and MCI patients show decreased fractional anisotropy in a wide variety of brain regions including areas known to be affected by AD such as the hippocampus (Sexton et al., 2011); many studies also note relationships between FA and de-”
BackgroundSpatial correlation between brain aerobic glycolysis and amyloid-β (Aβ) deposition
Vlassenko, A. G., Vaishnavi, S. N., Couture, L., Sacco, D., Shannon, B. J., Mach, R. H., Morris, J. C., Raichle, M. E., & Mintun, M. A. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1010461107 · Cited by 404 · cited 2×
“The DMN is also interesting in another respect; it overlaps with both Aβ deposition and with brain regions that preferentially utilize aerobic glycolysis (Vaishnavi et al., 2010; Vlassenko et al., 2010).”
BackgroundKaye, J. A., Swihart, T., Howieson, D., Dame, A., Moore, M. M., Karnos, T., Camicioli, R., Ball, M., Oken, B., & Sexton, G. (1997) · Neurology · doi:10.1212/wnl.48.5.1297 · Cited by 399 · cited 2×
“…and entorhinal cortex size appear to correspond to early memory decline and anticipate progression to more severe clinical stages, including mild cognitive impairment (MCI) and Alzheimer's dementia (de Leon et al., 1989; Dickerson et al., 2001; Jack et al., 2004, 2005; Kaye et al., 1997).”
BackgroundHaag, M. D. M., Hofman, A., Koudstaal, P. J., Stricker, B. H. C., & Breteler, M. M. B. (2009) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2008.150433 · Cited by 393 · cited 1×
“…growing number of clinically affected AD patients, the healthy lifestyle interventions suggested but not proven to reduce the risk of AD symptoms (Haag et al., 2009; Lautenschlager et al., 2008; Peila et al., 2006; Scarmeas et al., 2009; Szekely et al., 2008; Wang et al., 2002; Willis et al.,…”
BackgroundKlunk, W. E., Price, J. C., Mathis, C. A., Tsopelas, N. D., Lopresti, B. J., Ziolko, S. K., Bi, W., Hoge, J. A., Cohen, A. D., Ikonomovic, M. D., et al. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.0730-07.2007 · Cited by 389
Relationship between atrophy and β‐amyloid deposition in Alzheimer disease
Chételat, G., Villemagne, V. L., Bourgeat, P., Pike, K. E., Jones, G., Ames, D., Ellis, K. A., Szoeke, C., Martins, R. N., O'Keefe, G. J., et al. (2010) · Annals of Neurology · doi:10.1002/ana.21955 · Cited by 373 · cited 2×
“Indeed, several other studies have noted that Aβ in normal people is accompanied by subtle evidence of brain atrophy that may be even more important than Aβ itself in leading to cognitive decline (Chetelat et al., 2010; Dickerson et al., 2009; Jack et al., 2009; Mormino et al., 2009).”
BackgroundMicroglial activation and amyloid deposition in mild cognitive impairment: A PET study
Okello, A., Edison, P., Archer, H. A., Turkheimer, F. E., Kennedy, J., Bullock, R., Walker, Z., Kennedy, A., Fox, N., Rossor, M., et al. (2009) · Neurology · doi:10.1212/01.wnl.0000338622.27876.0d · Cited by 367
Longitudinal cognitive decline is associated with fibrillar amyloid-beta measured by [ 11 C]PiB
Resnick, S. M., Sojkova, J., Zhou, Y., An, Y., Ye, W., Holt, D. P., Dannals, R. F., Mathis, C. A., Klunk, W. E., Ferrucci, L., et al. (2010) · Neurology · doi:10.1212/wnl.0b013e3181d3e3e9 · Cited by 288 · cited 3×
“…saturated by the time patients have MCI (Doraiswamy et al., 2009; Forsberg et al., 2008; Grimmer et al., 2009; Jack et al., 2008; Kemppainen et al., 2007; Klunk et al., 2004, 2006; Morris et al., 2009; Resnick et al., 2010; Rowe et al., 2007, 2010; Villemagne et al., 2011; Wolk et al., 2009) (Fig.”
BackgroundEARLY MARKER FOR ALZHEIMER'S DISEASE: THE ATROPHIC HIPPOCAMPUS
De Leon, M., George, A., Stylopoulos, L., Smith, G., & Miller, D. (1989) · The Lancet · doi:10.1016/s0140-6736(89)90911-2 · Cited by 284 · cited 1×
“…and entorhinal cortex size appear to correspond to early memory decline and anticipate progression to more severe clinical stages, including mild cognitive impairment (MCI) and Alzheimer's dementia (de Leon et al., 1989; Dickerson et al., 2001; Jack et al., 2004, 2005; Kaye et al., 1997).”
BackgroundLangbaum, J. B. S., Chen, K., Lee, W., Reschke, C., Bandy, D., Fleisher, A. S., Alexander, G. E., Foster, N. L., Weiner, M. W., Koeppe, R. A., et al. (2009) · NeuroImage · doi:10.1016/j.neuroimage.2008.12.072 · Cited by 279 · cited 2×
“CMRgl reductions are correlated with clinical severity (Bokde et al., 2005; Choo et al., 2007; Haxby et al., 1990; Landau et al., 2011; Langbaum et al., 2009), and predict subsequent clinical decline and/or the neuropathological diagnosis of AD (Alexander et al., 2002a; Herholz et al., 1999;…”
BackgroundSelf-citationDissociating atrophy and hypometabolism impact on episodic memory in mild cognitive impairment
Chetelat, G. (2003) · Brain · doi:10.1093/brain/awg196 · Cited by 264 · cited 2×
“There is of course also evidence that FDG-PET and MRI are predictive of decline (Chetelat et al., 2003a; Jack et al., 1999).”
BackgroundKennedy, A. M., Frackowiak, R. S. J., Newman, S. K., Bloomfield, P. M., Seaward, J., Roques, P., Lewington, G., Cunningham, V. J., & Rossor, M. N. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(95)11270-7 · Cited by 250
Mosconi, L., De Santi, S., Brys, M., Tsui, W. H., Pirraglia, E., Glodzik-Sobanska, L., Rich, K. E., Switalski, R., Mehta, P. D., Pratico, D., et al. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.05.030 · Cited by 238
Lifespan brain activity, β-amyloid, and Alzheimer's disease
Jagust, W. J., & Mormino, E. C. (2011) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2011.09.004 · Cited by 221 · cited 1×
“In addition, it is possible that lifelong patterns of increased brain activity might themselves predispose to the deposition of βamyloid (Jagust and Mormino, 2011). licated in the Default Mode Network and successful episodic memory retrieval in young ns preferentially associated with atrophy and…”
BackgroundReducing the Risk of Dementia: Efficacy of Long-Term Treatment of Hypertension
Peila, R., White, L. R., Masaki, K., Petrovitch, H., & Launer, L. J. (2006) · Stroke · doi:10.1161/01.str.0000217653.01615.93 · Cited by 181 · cited 2×
“…the healthy lifestyle interventions suggested but not proven to reduce the risk of AD symptoms (Haag et al., 2009; Lautenschlager et al., 2008; Peila et al., 2006; Scarmeas et al., 2009; Szekely et al., 2008; Wang et al., 2002; Willis et al., 2006; Zandi et al., 2004), and the possibility…”
BackgroundSzekely, C. A., Green, R. C., Breitner, J. C. S., Østbye, T., Beiser, A. S., Corrada, M. M., Dodge, H. H., Ganguli, M., Kawas, C. H., Kuller, L. H., et al. (2008) · Neurology · doi:10.1212/01.wnl.0000313933.17796.f6 · Cited by 121 · cited 2×
“…but not proven to reduce the risk of AD symptoms (Haag et al., 2009; Lautenschlager et al., 2008; Peila et al., 2006; Scarmeas et al., 2009; Szekely et al., 2008; Wang et al., 2002; Willis et al., 2006; Zandi et al., 2004), and the possibility that investigational AD treatmentsmay need to…”
BackgroundFellgiebel, A., Dellani, P. R., Greverus, D., Scheurich, A., Stoeter, P., & Müller, M. J. (2006) · Psychiatry Research: Neuroimaging · doi:10.1016/j.pscychresns.2006.01.006 · Cited by 118
Cerebral glucose metabolism in patients with AD and different APOE genotypes
Drzezga, A., Riemenschneider, M., Strassner, B., Grimmer, T., Peller, M., Knoll, A., Wagenpfeil, S., Minoshima, S., Schwaiger, M., & Kurz, A. (2005) · Neurology · doi:10.1212/01.wnl.0000148478.39691.d3 · Cited by 116
Langbaum, J. B. S., Chen, K., Caselli, R. J., Lee, W., Reschke, C., Bandy, D., Alexander, G. E., Burns, C. M., Kaszniak, A. W., Reeder, S. A., et al. (2010) · Archives of Neurology · doi:10.1001/archneurol.2010.30 · Cited by 100
Self-citation
Cited by
Magnetic resonance imaging in Alzheimer’s disease and mild cognitive impairment
Initiative, F. T. A. D. N., Chandra, A., Dervenoulas, G., & Politis, M. (2019) · Journal of Neurology · doi:10.1007/s00415-018-9016-3 · Cited by 382
Changes in Brain Function Occur Years before the Onset of Cognitive Impairment
Beason-Held, L. L., Goh, J. O., An, Y., Kraut, M. A., O'Brien, R. J., Ferrucci, L., & Resnick, S. M. (2013) · The Journal of Neuroscience · doi:10.1523/jneurosci.1402-13.2013 · Cited by 293
González‐Domínguez, R., García, A., García‐Barrera, T., Barbas, C., & Gómez‐Ariza, J. L. (2014) · ELECTROPHORESIS · doi:10.1002/elps.201400196 · Cited by 119
Banik, A., Brown, R. E., Bamburg, J., Lahiri, D. K., Khurana, D., Friedland, R. P., Chen, W., Ding, Y., Mudher, A., Padjen, A. L., et al. (2015) · Journal of Alzheimer’s Disease · doi:10.3233/jad-150136 · Cited by 102
Ahnaou, A., Moechars, D., Raeymaekers, L., Biermans, R., Manyakov, N. V., Bottelbergs, A., Wintmolders, C., Van Kolen, K., Van De Casteele, T., Kemp, J. A., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-13839-6 · Cited by 98
Metadata
- Authors
- Reiman, E. M., & Jagust, W. J.
- Venue
- NeuroImage
- Publisher
- Elsevier BV
- Published
- 2012-06
- Volume
- 61
- Issue
- 2
- Pages
- 505-516
- ISSN
- 1053-8119 (ISSN-L)
- OpenAlex
- W2052041752
- Cited by
- 130
- References
- 80
- FWCI
- 7.68
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.